147 related articles for article (PubMed ID: 22271068)
1. Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma.
Russo V; Stella A; Barone A; Scott IU; Noci ND
Int Ophthalmol; 2012 Feb; 32(1):71-5. PubMed ID: 22271068
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
[TBL] [Abstract][Full Text] [Related]
3. [The Use of anti-VEGF preparations and PDT in the treatment of retinal juxtapapillary hemangioma - a case report].
Matušková V; Vysloužilová D
Cesk Slov Oftalmol; 2014 Oct; 70(5):196-200. PubMed ID: 25640043
[TBL] [Abstract][Full Text] [Related]
4. Retinal capillary hemangioma treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide.
Suh SC; Jin SY; Bae SH; Kim CG; Kim JW
Korean J Ophthalmol; 2007 Sep; 21(3):178-84. PubMed ID: 17804927
[TBL] [Abstract][Full Text] [Related]
5. Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
Mennel S; Meyer CH; Callizo J
Acta Ophthalmol; 2010 Aug; 88(5):610-3. PubMed ID: 19222401
[TBL] [Abstract][Full Text] [Related]
6. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma.
Kwon HJ; Kim M; Lee CS; Lee SC
Am J Ophthalmol; 2012 Jul; 154(1):137-145.e1. PubMed ID: 22465363
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma.
Agarwal A; Kumari N; Singh R
Int Ophthalmol; 2016 Oct; 36(5):747-50. PubMed ID: 26815929
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma.
Kreusel KM; Bornfeld N; Lommatzsch A; Wessing A; Foerster MH
Ophthalmology; 1998 Aug; 105(8):1386-92. PubMed ID: 9709747
[TBL] [Abstract][Full Text] [Related]
9. Atypical Exophytic Retinal Capillary Hemangioma and Diagnostic Modalities.
Shechtman DL; Gold AS; McIntosh S; Steen J; Murray TG
Optom Vis Sci; 2016 Jan; 93(1):107-12. PubMed ID: 26583797
[TBL] [Abstract][Full Text] [Related]
10. Functional and anatomic response of the retina and the choroid to intravitreal bevacizumab for macular edema.
Forte R; Cennamo G; Breve MA; Vecchio EC; de Crecchio G
J Ocul Pharmacol Ther; 2012 Feb; 28(1):69-75. PubMed ID: 22059904
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
12. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for retinal capillary haemangioma: longterm results.
Ach T; Thiemeyer D; Hoeh AE; Schaal KB; Dithmar S
Acta Ophthalmol; 2010 Jun; 88(4):e137-8. PubMed ID: 19681788
[No Abstract] [Full Text] [Related]
14. Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with Ruthenium-106 plaque radiotherapy.
Kubicka-Trząska A; Karska-Basta I; Oleksy P; Romanowska-Dixon B
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2015-9. PubMed ID: 26004077
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm.
Cho HJ; Rhee TK; Kim HS; Han JI; Lee DW; Cho SW; Kim JW
Am J Ophthalmol; 2013 May; 155(5):898-904. PubMed ID: 23385203
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
18. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion.
Kang HM; Chung EJ; Kim YM; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):501-8. PubMed ID: 22653439
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up.
Arevalo JF; Sanchez JG; Fromow-Guerra J; Wu L; Berrocal MH; Farah ME; Cardillo J; Rodríguez FJ;
Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):735-43. PubMed ID: 19189118
[TBL] [Abstract][Full Text] [Related]
20. Clinical Results of Various Treatments for Retinal Capillary Hemangioma.
Won YK; Lee MW; Shin YI; Kim JY; Jo YJ
Korean J Ophthalmol; 2020 Apr; 34(2):133-142. PubMed ID: 32233147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]